Latest: CytoSMART Technologies joins the Axion BioSystems brand
Latest: Early Detection Summit heads to London in March 2023
Latest: Mass spectrometry webinars that you won't want to miss
Latest: Nitrogen carrier gas: A viable alternative to helium
Latest: How Analytik Jena's technologies safeguard the circular economy of valuable metals
Latest: Get involved in our festive reviews giveaway!
Latest: The countdown has begun! Register today for the Virtual Analytical Summit 2023
Oligonucleotide handling and stability
CRISPR-generated CAR T-cells: A new frontier in the treatment of solid tumors
CytoSMART Technologies joins the Axion BioSystems brand
Axcend Focus LC delivers small HPLC with the perfect balance of sensitivity, robustness and...
Mass spectrometry webinars that you won't want to miss
The importance of protein biomarkers in drug development: A roundtable discussion
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
LC-MS/MS analysis of per- and polyfluoroalkyl substances
Rodent cardiovascular telemetry
Automation of the Agilent SureSelect XT Library Prep Kit with the Human All Exon V6 Panel on the...
Antibody-dependent cellular cytotoxicity of natural killer cells
Multiplexing Technology
Water Purification
Microscopy
Biophysical Characterization Technology
Liquid Handling
HPLC Technology
SLAS 2023 Building Biology...
20 Apr 23 - 21 Apr 23
DDS' LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies. Read more...
DDS's expert biomarker teams support non-clinical and clinical biomarker method development, validation and sample analysis. DDS's capabilities span from measuring single to multiple analyte profiles, such as those employed to mon... Read more...
DDS is an established biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...
DDS's flow cytometry service offers a range of assays to support pre-clinical through to late phase drug development. Read more...
DDS's bioanalytical solutions have helped its clients develop new peptide therapeutics to improve the quality of life. Applying their experience and cutting-edge technology, DDS has developed and validated methods usin... Read more...
Focused strategic science team, and one of the largest purpose-built bioanalytical facilities in Europe. Read more...
DDS has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...
DDS scientists are highly skilled in the accurate quantification of trace metals in challenging matrices. Offering you in-depth technical knowledge and extensive experience in the quantitation of elemental impurities in pharmaceutical mat... Read more...
Extractables and leachables studies are essential in providing the necessary analytical data for regulatory submission. Read more...
DDS is experienced in the measurement of a materials physical and solid form properties on a wide range of materials including active ingredients, excipients, and formulated products. DDS's expertise covers all stages of developm... Read more...
With many years’ experience in both pharmaceutical and forensic analysis, DDS has in-depth knowledge and expertise in a wide range of foreign particulate types and their likely origin. Read more...
Our Impurity and Contamination Centre of Excellence are experts in the identification and quantification of trace impurities in a wide range of materials used throughout the global pharmaceutical and healthcare sectors. Read more...
Rapid LC-MS bioanalysis services, delivering reliable results on-time for preclinical studies, through to Phase I and large Phase II-III clinical programs. Read more...
Immunogenicity bioanalysis solutions for pre-clinical and clinical assessments. Read more...